Data linkage and sharing for healthy longevity: A global challenge
Data linkage and sharing for healthy longevity together present a global challenge, in the view of Prof Makoto Suematsu, Japan Agency for Medical Research and Development and Rihana Diabo at the World Economic Forum.
Social media sites listen to NHS call for online protection
Facebook and Instagram have announced they are removing posts that promote 'miracle' cures like get-slim-quick products, which are known to have damaging side effects.
Medical marijuana: Developments in the industry
Ian C Tordoff, CEO of Block Commodities Ltd, provides a snap-shot of changes in the medical marijuana industry.
Social care exodus: One in three social carers plan to leave sector
New research from Totaljobs reveals one in three (37%) social carers are looking to leave the sector within the next five years in a social care exodus.
Regulation and quality control for the medical cannabis industry
AlphaCAT (Cannabinoid Analysis Test) takes the first step to regulation and quality control for the medical cannabis industry, as this profile by the firm’s Sebastien Beguerie sheds light on.
Beyond the current obesity epidemic
Obesity is a growing problem around the world, with many negative consequences for both individuals and societies. Research by Professor Barry M. Popkin and his colleagues at the University of North Carolina (UNC) aims to lead us beyond the current obesity epidemic.
The role of eHealth tools in idiopathic pulmonary fibrosis care and research
Karen Moor and Marlies Wijsenbeek from the Erasmus Medical Center, Rotterdam explore the role of eHealth tools in idiopathic pulmonary fibrosis care and research.
From diabetes prevention 1.0 to Prevention 3.0
Digitally enabled pathway personalisation is leveraging actionable data insights and dynamic intelligence to drive better outcomes as part of the Prevention 3.0 agenda
NHS supports survivors of female genital mutilation (FGM)
Hundreds of survivors of female genital mutilation (FGM) will be able to access expert care, support and treatment due to a new network of NHS clinics being launched.
Brexit ‘mini-deal’ can prevent Operation Yellowhammer, says NHS Confederation
Today (12 September) the NHS Confederation responded to the publication of Operation Yellowhammer, a document describing alarming food and medicine shortages after Brexit.
Recovery-focused mental healthcare
Jaime Essed, Founder and CEO of the company Oh My Mood, turns the spotlight onto Recovery-focused mental healthcare.
NHS calls for crackdown on sales of 25 inch knives
A leading trauma surgeon has led the call for more to be done to restrict the sale of harmful 25-inch knives to help prevent violent crime.
The prevalence of diabetes in the African region
In this interview, Jean-Marie Dangou from the WHO Regional Office for Africa discusses diabetes in the African region, including lack of access to treatment and ongoing action to solve this.
Precision medicine: Cost-effectiveness of breakthrough treatments
Dr Gerry Morrow shares his thoughts on the precision medicine, defined as the cost-effectiveness of breakthrough treatments and explains why this area is a priority for both researchers and government.
Medication management in diabetes
PillTime Ltd highlights the importance of medication management for diabetes as it remains a significant burden on the NHS.
Emotional fitness for university students
Nick Bennett, CEO at Fika, puts forward the case for a positive and preventative approach to mental health for university students, drawing on learnings from physical fitness and positive psychology.
Healthcare early detection technology: Voice analysis technology
Shinichi Tokuno from the Department of Voice Analysis of Pathophysiology, Graduate School of Medicine, at the University of Tokyo, lifts the lid on voice analysis technology for healthcare.
Europe setting standards for cannabis products
As government authorities come to grips with legislation of cannabis-based products, the European market holds a key position, Liam McGreevy, CEO, Ethnopharm Ltd explains.
Government to invest over £130 million in new NHS technology
Patients will benefit from significant government investment in new NHS technology to improve treatment, diagnosis and care options for diseases including cancer.
Cannabis products: Greater diversity, increased potency and close monitoring
A recent European Monitoring Centre for Drugs and Drug Addiction report highlights the need for diversity of cannabis products, increased potency and close monitoring of health effects.
